LFCR(Lifecore Biomedical, Inc.) · 财务报表

LFCR(Lifecore Biomedical, Inc.) 的财务报表:医疗保健,特药与仿制药。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2021-05-30FY 截至 2022-05-29FY 截至 2023-05-28FY 截至 2024-05-26FY 截至 2025-05-25
营业收入$100.87M$111.27M$103.27M$128.26M$128.87M
毛利润$38.94M$39.07M$27.98M$41.85M$40.30M
营业利润−$8.82M−$11.79M−$21.80M−$8.84M−$17.25M
净利润−$32.29M−$116.72M−$99.56M$12.01M−$38.72M
经营现金流$16.47M−$22.59M−$17.44M$257.00K−$206.00K
自由现金流−$2.79M−$48.82M—−$18.14M−$13.62M
摊薄每股收益$-1.10$-3.97$-3.32$0.33$-1.27

Lifecore Biomedical, Inc. LFCR